Skip to main content
. 2020 Jan 29;132(7-8):188–196. doi: 10.1007/s00508-019-01606-8

Table 2.

Laboratory findings of the patients admitted with dengue and/or malarial infections

Entire sample
(n = 85)
Dengue (D)
(n = 48)
Malaria (M)
(n = 18)
p-value
(D vs. M)
Multiple infections
(Mul) (n = 19)
p-value
(D vs. M vs. Mul)
Labs on admission, median (IQR)
Hemoglobin (g/dl) 10.6 (9.6–11.8) 10.7 (10.2–11.9) 9.9 (9.3–10.9) 0.11 10.80 (9.8–11.7) 0.38
Hematocrit (%) 32.7 (29.1–35.3) 33.2 (30.8–35.8) 32.3 (27.0–32.7) 0.05 33.4 (29.7–35.3) 0.28
WBC (×109/l) 6.3 (4.6–9.6) 5.90 (4.40–7.95) 6.00 (4.20–8.05) 0.75 11.5 (6.3–17.1) <0.01
Platelets (×109/l) 101 (53–157) 114 (47–170) 91 (68–134) 0.23 89 (50–171) 0.63
Missing 1 (1%) 1 (2%) 0 (0%) 0 (0%)
Dengue labs, n (%)
Any dengue test positive 55 (65%) 43 (90%) 12 (63%)
Dengue Ag
Positive 21 (24%) 18 (38%) 3 (16%)
Negative 6 (7%) 5 (10%) 1 (5%)
Dengue Ab
Positive 35 (41%) 24 (50%) 11 (58%)
Negative 8 (9%) 4 (8%) 1 (5%)
Dengue PCR
Positive 4 (5%) 4 (8%)
Negative 2 (2%) 2 (4%)
Malaria labs, n (%)
Any malaria test positive 25 (29%) 17 (94%) 8 (42%)
MP-ICT
Positive 16 (19%) 12 (67%) 4 (21%)
Negative 46 (54%) 9 (47%)
Microscopy for malaria
Positive 18 (21%) 12 (67%) 6 (32%)
Negative 45 (53%) 3 (17%) 10 (53%)
Markers of liver function, median (IQR)
ALT (units/l) 55 (28–162) 63 (31–174) 31 (13–53) <0.01 70 (33–182) 0.02
Missing 10 (12%) 5 (10%) 4 (22%) 1 (5%)
Total bilirubin levels (µmol/l) 0.8 (0.4–1.3) 0.50 (0.3–0.9) 1.2 (0.9–2.9) 0.11 0.9 (0.5–2.6) 0.87
Missing 32 (37%) 21 (44%) 7 (39%) 4 (21%)

WBC White blood cell count, Ag antigen, Ab Antibody, PCR polymerase chain reaction, MP-ICT Malaria P. falciparum/ P. vivax immunochromatographic test, ALT alanine aminotrasferase